Imagine trying to design a key for a lock that is constantly changing its shape. That is the exact challenge we face in modern drug discovery when dealing with intrinsically disordered proteins.
When Anthropic announced the start of testing on Friday, security vendors, and the markets, sat up and took notice. But is ...